Riskpilot← Back to searchSign inGet full accessBASE life science A/S
A/SActiveCVR 30906942Lyngbyvej 2Business and other management consultancy activities · NACE 7020Est. 2007104 employeeswww.baselifescience.com
Revenue 2025
DKK 93,9M
+1% vs 2024
EBITDA margin
-38.7%
+40% vs 2024
Equity ratio
24.4%
Financial strength
Net profit 2025
DKK -50M
+43% vs 2024
| Revenue | DKK 93,9M | +1% |
| EBITDA | DKK -36,4M | +40% |
| Net profit | DKK -50M | +43% |
| Total assets | DKK 197,3M | +26% |
| Equity | DKK 48,1M | +173% |
| Employees | 104 | — |
Legal name
BASE life science A/S
CVR number
30906942
Legal form
Aktieselskab
NACE code
7020 · Business and other management consultancy activities
Founded
8. oktober 2007
Share capital
DKK 600.400
Employees
104 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af tre medlemmer af bestyrelsen i forening, af en direktør alene eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed med rådgivning inden for forretningsudvikling.
Address
Lyngbyvej 2
Phone
+4588202120
Email
contact@baselifescience.com
Website
www.baselifescience.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.812 | 9.292 | 9.031 | 5.738 | 15.364 | 26.586 | 38.539 | 49.217 | 65.461 | 93.830 | 117.471 | 84.928 | 93.372 | 93.921 |
| Staff expenses | -7.551 | -7.508 | -8.622 | -8.051 | -11.726 | -25.254 | -35.117 | -39.680 | -49.484 | -76.910 | -92.370 | -147.349 | -153.669 | -130.296 |
| EBITDA | 1.031 | 242 | 409 | -2.313 | 3.637 | 1.332 | 3.421 | 9.538 | 15.977 | 16.919 | 25.101 | -62.421 | -60.296 | -36.375 |
| Depreciation & amort. | -0 | -0 | -0 | -25 | -107 | -273 | -308 | -351 | -89 | -138 | -904 | -2.850 | -3.717 | -2.886 |
| EBIT | 1.031 | 242 | 409 | -2.338 | 3.530 | 1.059 | 3.112 | 9.187 | 15.889 | 16.781 | 24.198 | -65.271 | -64.013 | -39.261 |
| Net financials | -27 | -49 | -36 | -114 | -108 | -102 | -260 | -159 | -114 | -171 | -204 | 34.011 | -23.911 | -11.555 |
| Profit before tax | 1.004 | 193 | 373 | -2.452 | 3.422 | 958 | 2.853 | 9.028 | 15.774 | 16.610 | 23.994 | -31.259 | -87.924 | -50.815 |
| Tax | 261 | 65 | 103 | -200 | 806 | 222 | 644 | 1.901 | 3.473 | 2.848 | 6.235 | -35 | -3 | -812 |
| Net profit | 744 | 128 | 271 | -2.252 | 2.616 | 736 | 2.208 | 7.126 | 12.301 | 13.762 | 17.759 | -31.224 | -87.921 | -50.004 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.679 | 2.432 | 3.091 | 3.067 | 8.133 | 12.804 | 14.558 | 24.070 | 37.768 | 54.153 | 96.512 | 154.647 | 155.970 | 197.257 |
| Equity | 1.267 | 725 | 881 | -1.615 | 1.001 | 936 | 3.145 | 9.645 | 18.647 | 26.169 | 40.743 | 21.496 | -66.213 | 48.122 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.818 | 1.923 | 0 | 0 | 97.380 | 36.820 |
| Short-term debt | 1.312 | 1.648 | 2.151 | 4.682 | 7.064 | 11.530 | 11.347 | 14.420 | 16.303 | 24.811 | 54.503 | 132.132 | 124.001 | 111.584 |
| Total debt | 1.312 | 1.648 | 2.151 | 4.682 | 7.064 | 11.530 | 11.347 | 14.420 | 19.121 | 26.734 | 54.503 | 132.132 | 221.380 | 148.403 |
EBITDA margin
-38.7%
This company
15.8%
Market median
-345% vs market
20122025
Equity ratio
24.4%
This company
38.2%
Market median
-36% vs market
20122025
Return on equity
-103.9%
This company
18.4%
Market median
-665% vs market
20122025
Net profit margin
-53.2%
This company
8.1%
Market median
-757% vs market
20122025
Asset turnover
0.48×
This company
1.12×
Market median
-57% vs market
20122025
Debt / equity
3.10×
This company
0.62×
Market median
-400% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MW Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
JW Management | Management | 2016 | — | — |
SK Management | Management | 2015 | — | — |
TD Management | Management | 2007 | — | — |
NA Management | Management | 2007 | — | — |
TK Management | Management | 2015 | — | — |
JV Management | Management | 2008 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Chairman | 2018 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2022 | |
INTRAWORLD HOLDING ApS | Company | 10.0% | 10.0% | 2015 |
A. Dumas ApS | Company | 100.0% | 100.0% | 2017 |
Hanefeld Holding ApS | Company | 15.0% | 15.0% | 2018 |
Aravis Holding ApS | Company | 15.0% | 15.0% | 2018 |
Ninja Holding ApS | Company | 15.0% | 15.0% | 2018 |
HANSGAARD HOLDING ApS | Company | 33.3% | 33.3% | 2013 |
Gloomy Sunday ApS | Company | 15.0% | 15.0% | 2018 |
BLÅ EKSTRA HOLDING ApS | Company | 10.0% | 10.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BASE life science A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Woergaard | Chief Executive Officer | 0 companies |
| Jacob Winkler | Management | 0 companies |
| Sam Kondo Steffensen | Management | 0 companies |
| Torsten Dahl Fredelund | Management | 0 companies |
| Nikolaj Aalund Brandt | Management | 0 companies |
| Thomas Kristian Röhme | Management | 0 companies |
| Jeppe Vilstrup Hansgaard | Management | 0 companies |
| Narahari Govindraju | Board of Directors | 0 companies |
| Jørgen Appel Kelkjær | Chairman | 0 companies |
| Satish Chaluve Gowda Hullangala | Chairman | 0 companies |
| Baptiste Gilbert Célestin Mercier | Board of Directors | 0 companies |
| Amanda Thera van den Hoven | Board of Directors | 0 companies |
| Subhro Mallik | Board of Directors | 0 companies |
| Mohit Joshi | Chairman | 0 companies |
| Dinesh Ramakrishna Rao | Board of Directors | 0 companies |
| Peter Nistrup Lind Larsen | Board of Directors | 0 companies |
| Jacob Bo Hanefeld Dziegiel | Board of Directors | 0 companies |